Instone Real Estate Group AG (INS)
XETRA Stock Exchange · Germany · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 5.940 |
|---|---|
| 52-week range | 5.660 – 9.638 |
| Return, 1 month / 3 months | −1.0% / −25.4% |
| Return, 1 year / 3 years | −30.2% / +29.9% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 40.6% |
| Worst drawdown (1 year) | -39.1% |
| Average daily value traded | 0.09M EUR |
| Dividend yield | 7.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Instone Real Estate Group is a German residential property developer based in Essen. It plans, builds and sells apartments and residential quarters, mainly in urban locations across Germany, serving private buyers and investors. The company handles projects from land acquisition through construction to handover, and its work covers new-build homes and redevelopment of existing sites.
On this site Instone Real Estate Group AG appears as a stock on the XETRA Stock Exchange (Germany), code INS, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Instone Real Estate Group AG (INS) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 5.940 on 19 October 2026.
Its price-based Market X-Ray is 30 out of 100 (a weak price profile), ranking 569 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 30.2% and over the last three months it fell 25.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 18 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -23.0% | ||
| From 52-week high | -37.0% | ||
| Momentum | 13 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -25.4% | ||
| 6-month return | -26.4% | ||
| 12-month return, skipping the last month | -29.5% | ||
| Risk (lower is better) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility (1 year) | 40.6% | ||
| Worst drawdown (1 year) | -39.1% | ||
| Liquidity | 43 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.09M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 71 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 7.2% | ||
| Years with dividends | 5 |
Strengths
- Income: Dividend is high and has been paid regularly.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Risk (lower is better): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −0.7% |
|---|---|
| 1 month | −1.0% |
| 3 months | −25.4% |
| 6 months | −26.4% |
| 1 year | −30.2% |
| 3 years | +29.9% |
| 5 years | −66.5% |
Signals
| 50-day / 200-day average | 6.786 / 7.711 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.233 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 4 Jun 2026 | EUR 0.4300 |
| 12 Jun 2025 | EUR 0.5000 |
| 6 Jun 2024 | EUR 0.3300 |
| 15 Jun 2023 | EUR 0.3500 |
| 10 Jun 2022 | EUR 0.6200 |
| 10 Jun 2021 | EUR 0.2600 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.